Position in EXEL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$107,803,125
+$22,622,090 QoQ
Shares Held
1,981,311
-0.2% QoQ
Ownership
0.800%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#29
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. EXEL ranks #9 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $107,803,125 | 1,981,311 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $85,181,035 | 1,986,035 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $89,589,827 | 2,044,030 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $96,213,052 | 2,329,614 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $105,822,365 | 2,400,689 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $91,445,553 | 2,476,857 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $81,971,875 | 2,461,618 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $64,614,352 | 2,489,956 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $61,601,139 | 2,741,484 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $65,863,060 | 2,775,519 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $71,895,576 | 2,996,898 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $66,489,805 | 3,043,012 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $59,856,296 | 3,132,198 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $58,715,129 | 3,024,994 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $49,112,085 | 3,061,851 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $49,686,526 | 3,168,784 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $74,958,510 | 3,600,313 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $70,950,226 | 3,129,697 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $52,922,168 | 2,895,086 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $62,799,916 | 2,970,668 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $54,367,164 | 2,983,928 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $67,623,635 | 2,993,521 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $62,433,451 | 3,110,785 | Shares | Other | 2021-02-09 | |
| 2020-09-30 | $78,734,986 | 3,220,245 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $79,110,980 | 3,332,392 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $57,195,054 | 3,321,432 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||